Related Experiment Videos
Tissue factor and tissue factor pathway inhibitor in kidney allograft recipients
J S Malyszko1, J Malyszko, M Mysliwiec
1Department of Nephrology and Internal Medicine, Bialystok School of Medicine, Zurawia, Poland.
Transplantation Proceedings
|August 24, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Vitamin D Concentration in Patients After Heart and Kidney Transplantation.
Transplantation proceedings·2018
Future Lawyers Support Organ Donation and Transplantation.
Transplantation proceedings·2018
Opinions and Attitudes of Medical Students About Organ Donation and Transplantation.
Transplantation proceedings·2018
Kallistatin Concentration and Hypertension in Heart Transplant Recipients.
Transplantation proceedings·2018
Underrecognition and Underestimation of Disturbances in Calcium-Phosphate Balance in Kidney Transplant Recipients.
Transplantation proceedings·2018
Endocan Concentration in Kidney Transplant Recipients.
Transplantation proceedings·2018
Successful Heart and Renal Allograft Transplantation From Patients With Child-Pugh Class C Cirrhosis.
Transplantation proceedings·2026
Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling.
Transplantation proceedings·2026
Risk-Stratified 2 mg/kg ATG Induction in Kidney Transplantation: Comparing Two- and Three-Dose Regimens at a Single Center.
Transplantation proceedings·2026
Hypothermic Machine Perfusion Modifies the Impact of Cold Ischemia Time on Kidney Transplant Outcomes: A Single-Center Analysis.
Transplantation proceedings·2026
Feasibility of 8 Gy TBI-Busulfan-Fludarabine Conditioning with Post-Transplant Cyclophosphamide for Pediatric High-Risk or Relapsed Acute Lymphoblastic Leukemia.
Transplantation and cellular therapy·2026